A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinical trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission.
source https://www.sciencedaily.com/releases/2026/03/260315225121.htm
Judge sides with Subnautica 2 founders in lawsuit against publisher Krafton
over long Early Access delay, $250 million bonus — the former CEO is back,
too
-
Eight months after it began, the legal battle between Subnautica 2's
creators and its publisher Krafton has ended in victory for Unknown Worlds'
leadership...
15 hours ago
No comments:
Post a Comment